NCT06157866

Brief Summary

This study will evaluate the impact of a novel non-pharmacological multimodal therapy, a type of approach known to improve pain outcomes and recommended by the Institute of Medicine report for chronic pain management. This study design will also allow the investigators to evaluate a neural model supporting therapeutic alliance for pain outcomes for fibromyalgia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Feb 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Feb 2024Jun 2027

First Submitted

Initial submission to the registry

November 5, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 6, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

February 16, 2024

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

October 24, 2025

Status Verified

October 1, 2025

Enrollment Period

3.4 years

First QC Date

November 5, 2023

Last Update Submit

October 22, 2025

Conditions

Keywords

hyperscan fmrihyperscan EEGacupuncturefibromyalgiachronic pain

Outcome Measures

Primary Outcomes (1)

  • Brain Imaging-fMRI

    Hyperscan fMRI assessing brain-to-brain concordance between the patient and the clinician.

    Up to 6 months

Secondary Outcomes (1)

  • Brain Imaging-EEG

    Up to 6 months

Other Outcomes (1)

  • Brief Pain Inventory (BPI) - Pain Interference

    Up to 6 months

Study Arms (2)

Cognitive Training

EXPERIMENTAL

Participants will meet with a pain specialist who will conduct a specific form of cognitive training targeting fibromyalgia.

Other: ElectroacupunctureBehavioral: Cognitive Training

Education Training

ACTIVE COMPARATOR

Participants will meet with a pain specialist to receive education training related to fibromyalgia.

Other: ElectroacupunctureBehavioral: Education Training

Interventions

During the treatment sessions the acupuncturist will insert needles in several locations aimed to reduce the patient's fibromyalgia pain. A low-amplitude, sub-sensory electrical current will be activated by the acupuncturist.

Cognitive TrainingEducation Training

Cognitive training with a pain specialist.

Cognitive Training

Education training with a pain specialist.

Education Training

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meet traditional American College of Rheumatology (ACR) criteria for FM as well as the more recent Wolfe et al 2011 criteria
  • Are on stable doses of medication for 30 days prior to entering the study and agree not to change medications or dosages during the trial
  • Ability to fully understand and consent to study procedures
  • Baseline pain intensity of at least 4/10
  • Pain duration of at least 6 months

You may not qualify if:

  • Any longer period of work experience involving pain treatment, pain rehabilitation etc.
  • Presence of any illness that is judged to interfere with the trial. For example: psychiatric disorder according to the DSM-IV manual
  • Presence of any contraindications to fMRI scanning. For example: cardiac pacemaker, metal implants, fear of closed spaces, pregnancy.
  • History of significant head injury
  • Inability to respond accurately to the pain-relieving intervention in the behavioral part of the experiment, indicating a lack of response to the expectancy manipulation. If the healthy volunteer or clinician is not a responder to the behavioral expectancy induction he or she will be excluded.
  • Unwillingness to receive brief experimental pain.
  • Leg pain or health issues that may interfere with the study procedures.
  • Comorbid acute pain condition
  • Comorbid chronic pain condition that is rated by the subject as more painful than fibromyalgia
  • Current use of opioid analgesics
  • Concurrent inflammatory or autoimmune disease
  • Documented peripheral neuropathy
  • Pregnant
  • Any psychiatric disorder involving a history of psychosis (e. g schizophrenia, bipolar disorder, severe personality disorders)
  • History of anxiety disorders or significant anxiety symptoms interfering with fMRI procedures (e.g., panic)
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Massachusetts General Hospital

Charlestown, Massachusetts, 02129, United States

RECRUITING

Spaulding Rehabilitation Hospital

Charlestown, Massachusetts, 02129, United States

RECRUITING

Brigham and Women's Hospital

Chestnut Hill, Massachusetts, 02467, United States

RECRUITING

MeSH Terms

Conditions

FibromyalgiaChronic Pain

Interventions

ElectroacupunctureCognitive TrainingSex Education

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesiaNeurological RehabilitationAftercareContinuity of Patient CarePatient CareHealth ServicesHealth Care Facilities Workforce and ServicesSexologyBehavioral SciencesBehavioral Disciplines and Activities

Study Officials

  • Vitaly Napadow, PhD

    Spaulding Rehabilitation Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seneca Ellis

CONTACT

Arvina Grahl, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 5, 2023

First Posted

December 6, 2023

Study Start

February 16, 2024

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

October 24, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Per NIH guidelines

Locations